Gilbert Christopher R, Feller-Kopman David, Akulian Jason, Hayes Margaret, Yarmus Lonny
Department of Pulmonary, Allergy, and Critical Care Medicine, Penn State College of Medicine-Milton S. Hershey Medical Center, Bronchoscopy and Interventional Pulmonary, Hershey, Pennsylvania.
Pediatr Pulmonol. 2014 Jun;49(6):597-604. doi: 10.1002/ppul.22855. Epub 2013 Jul 8.
Advanced training in interventional pulmonology (IP) includes a multidisciplinary approach to a wide variety of pathologic conditions affecting different age groups. The role of the interventional pulmonologist in the pediatric patient population has not been described. We report our experience of the care of pediatric patients by IP at an academic institution.
A retrospective review of inpatient and outpatient IP procedures from 2008 to 2011 was performed. All patients' less than 21 years of age at the time of their procedure were identified. Data regarding age, procedure performed, pre-operative diagnosis, results, and complications were collected.
Thirty-five patients younger than the age of 21, with 14 of these patients being under the age of 18, were identified. Fifty-six procedures were performed on the entire cohort, 30 as inpatient procedures and 26 as outpatient procedures. There were no deaths or major complications related to any procedure.
We identified a cohort of pediatric patients that were able to successfully undergo diagnostic and therapeutic procedures under the direction of an experienced IP team. Cases included the evaluation and management of both malignant and benign complex airway and pleural diseases. There was no major morbidity or mortality related to our procedures, demonstrating an ability to safely evaluate and manage complex airway and pleural disease in the pediatric population.
介入肺病学（IP）的高级培训包括采用多学科方法处理影响不同年龄组的多种病理状况。介入肺病专家在儿科患者群体中的作用尚未得到描述。我们报告了在一所学术机构中，介入肺病学专家对儿科患者的护理经验。
对2008年至2011年的住院和门诊介入肺病学手术进行回顾性研究。确定了所有手术时年龄小于21岁的患者。收集了有关年龄、所进行的手术、术前诊断、结果和并发症的数据。
确定了35名年龄小于21岁的患者，其中14名患者年龄小于18岁。对整个队列进行了56次手术，30次为住院手术，26次为门诊手术。没有与任何手术相关的死亡或重大并发症。
我们确定了一组儿科患者，他们能够在经验丰富的介入肺病学团队的指导下成功接受诊断和治疗手术。病例包括对恶性和良性复杂气道及胸膜疾病的评估和管理。我们的手术没有导致重大的发病率或死亡率，表明有能力在儿科人群中安全地评估和管理复杂气道及胸膜疾病。
